Correction to our Letter to the Editor about "CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer"

2018-12-20

New England Journal of Medicine , Volume 379 - Issue 25 p. 2481

Additional Metadata
Persistent URL	doi.org/10.1056/NEJMc1814750, hdl.handle.net/1765/113488
Journal	New England Journal of Medicine
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Coebergh van den Braak, R.R.J, Martens, J.W.M, & IJzermans, J.N.M. (2018). Correction to our Letter to the Editor about "CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer". New England Journal of Medicine, 379(25). doi:10.1056/NEJMc1814750

Publication